Canadian pharmacy Shoppers Drug Mart has entered the fray of medical cannabis sales with launch of its online commerce hub.

Shoppers, a subsidiary of Loblaw Companies (TSX:L), announced on Tuesday (January 8) the official launch of its medical cannabis e-commerce portal.

In total the store opened with 24 medical cannabis offerings from the various licensed producers (LPs), with an additional product list for accessories including vaporizers.

The move represents another validation of the medical cannabis market as an established retail brand in Canada adopts the industry and its participants.

“As medical cannabis is increasingly prescribed to Canadians for its therapeutic benefits, our goal is to enhance the service and support that patients receive through this process,” Jeff Leger, president of Shoppers, said.

In an intro video for the website, Shoppers explained consumers will need to register manually or through a doctor. The pharmacy also assembled a support group called the cannabis care advisors to aid customers with questions on products or doses.

Currently the service is only available for medical patients in Ontario. A warning message on the Shoppers site says the retailer is working to expand its service to the rest of Canada.

In its announcement, Shoppers revealed it is offering education to pharmacists through the a medical advisory board.

The platform from the prominent Canadian pharmacy offers cannabis products from eight different LPs, with five public ones and three being subsidiaries of the public producers, including:

Tilray (NASDAQ:TLRY), WeedMD (TSXV:WMD), Aphria (NYSE:APHA,TSX:APHA) and its subsidiary Broken Coast Cannabis, private producer Starseed Medicinal, Emblem (TSXV:EMC), Aurora Cannabis (NYSE:ACB,TSX:ACB) and its subsidiaries CanniMed and MedReleaf.

In a statement Nick Dean, CEO of Emblem, said accessing various distribution channels for his company’s products was a critical factor in its strategy.

Shoppers signed supply agreements with the producers it now lists on its new site throughout 2018. The amount of product the retailer took from each producer was undisclosed.

In December, Shoppers announced it had officially obtained its sale license from Health Canada, which allows it to sell dried flower, seeds and oils.

Update: Flowr joins the ranks of LPs with supply deals with Shoppers

On Wednesday (January 9) The Flowr Corporation (TSXV:FLWR) announced it had secured a supply agreement with Shoppers to begin offering its product on the new medical cannabis online shop.

Tom Flow, Flowr’s Co-CEO, called the agreement a “game-changing opportunity” for the company and its medical products.

The supply deal between Flowr and Shoppers will last three years, with an additional two year renewal term in the agreement.

The producer expects the direct-to-patient online exclusivity for its medical FlowRx products to “significantly increase its sales of medical cannabis products in Canada.”

Shares of Flowr in Toronto closed on Wednesday with a price of C$4.55, an increase in value of 4.60 percent.

In an email response, a Loblaw Companies representative told the Investing News Network (INN) Shoppers is exploring opportunities with other LPs but wouldn’t confirm any other new deals.

“We have signed supply agreements with [10 LPs] and will be introducing more products in the coming days and weeks from them.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Emblem and The Flowr Corporation are clients of the Investing News Network. This article is not paid-for content.

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact, or

Keep reading... Show less